These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11687904)

  • 1. Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins.
    Iida T; Kijima H; Urata Y; Goto S; Ihara Y; Oka M; Kohno S; Scanlon KJ; Kondo T
    Cancer Gene Ther; 2001 Oct; 8(10):803-14. PubMed ID: 11687904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression.
    Nagata J; Kijima H; Hatanaka H; Asai S; Miyachi H; Takagi A; Miwa T; Mine T; Yamazaki H; Nakamura M; Kondo T; Scanlon KJ; Ueyama Y
    Biochem Biophys Res Commun; 2001 Aug; 286(2):406-13. PubMed ID: 11500053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hammerhead ribozyme against gamma-glutamylcysteine synthetase attenuates resistance to ionizing radiation and cisplatin in human T98G glioblastoma cells.
    Tani M; Goto S; Kamada K; Mori K; Urata Y; Ihara Y; Kijima H; Ueyama Y; Shibata S; Kondo T
    Jpn J Cancer Res; 2002 Jun; 93(6):716-22. PubMed ID: 12079521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells.
    Goto S; Yoshida K; Morikawa T; Urata Y; Suzuki K; Kondo T
    Cancer Res; 1995 Oct; 55(19):4297-301. PubMed ID: 7671239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-expression of gamma-glutamylcysteine synthetase sub-units in response to cisplatin and doxorubicin in human cancer cells.
    Iida T; Mori E; Mori K; Goto S; Urata Y; Oka M; Kohno S; Kondo T
    Int J Cancer; 1999 Jul; 82(3):405-11. PubMed ID: 10399958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of multidrug resistance proteins MRP1 and MRP3 and gamma-glutamylcysteine synthetase gene expression by nonsteroidal anti-inflammatory drugs in human colon cancer cells.
    Tatebe S; Sinicrope FA; Kuo MT
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1427-33. PubMed ID: 11820781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of MRP1 and gamma-glutamylcysteine synthetase gene expression by interleukin 1beta is mediated by nitric oxide-related signalings in human colorectal cancer cells.
    Ikegami Y; Tatebe S; Lin-Lee YC; Xie QW; Ishikawa T; Kuo MT
    J Cell Physiol; 2000 Nov; 185(2):293-301. PubMed ID: 11025451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hammerhead ribozymes against gamma-glutamylcysteine synthetase mRNA down-regulate intracellular glutathione concentration of mouse islet cells.
    Kijima H; Tsuchida T; Kondo H; Iida T; Oshika Y; Nakamura M; Scanlon KJ; Kondo T; Tamaoki N
    Biochem Biophys Res Commun; 1998 Jun; 247(3):697-703. PubMed ID: 9647756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of heavy subunit of gamma-glutamylcysteine synthetase (gamma-GCSh) in human colorectal carcinoma.
    Tatebe S; Unate H; Sinicrope FA; Sakatani T; Sugamura K; Makino M; Ito H; Savaraj N; Kaibara N; Kuo MT
    Int J Cancer; 2002 Jan; 97(1):21-7. PubMed ID: 11774239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levels.
    Tonigold M; Rossmann A; Meinold M; Bette M; Märken M; Henkenius K; Bretz AC; Giel G; Cai C; Rodepeter FR; Beneš V; Grénman R; Carey TE; Lage H; Stiewe T; Neubauer A; Werner JA; Brendel C; Mandic R
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1689-704. PubMed ID: 24913304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for altered regulation of gamma-glutamylcysteine synthetase gene expression among cisplatin-sensitive and cisplatin-resistant human ovarian cancer cell lines.
    Yao KS; Godwin AK; Johnson SW; Ozols RF; O'Dwyer PJ; Hamilton TC
    Cancer Res; 1995 Oct; 55(19):4367-74. PubMed ID: 7671249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.
    Hatanaka H; Abe Y; Naruke M; Asai S; Miyachi H; Kawakami T; Nagata J; Kamochi J; Kijima H; Yamazaki H; Scanlon KJ; Ueyama Y; Nakamura M
    Anticancer Res; 2001; 21(2A):879-85. PubMed ID: 11396179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human multidrug resistance-associated protein (MRP) gene family: from biological function to drug molecular design.
    Ishikawa T; Kuo MT; Furuta K; Suzuki M
    Clin Chem Lab Med; 2000 Sep; 38(9):893-7. PubMed ID: 11097346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of glutathione synthesis reverses Krüppel-like factor 4-mediated cisplatin resistance.
    Jia Y; Zhang W; Liu H; Peng L; Yang Z; Lou J
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):377-85. PubMed ID: 21833590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel.
    Takara K; Obata Y; Yoshikawa E; Kitada N; Sakaeda T; Ohnishi N; Yokoyama T
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):785-93. PubMed ID: 16534613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitivities of the MRP gene family and gamma-glutamylcysteine synthetase to prooxidants in human colorectal carcinoma cell lines with different p53 status.
    Lin-Lee YC; Tatebe S; Savaraj N; Ishikawa T; Tien Kuo M
    Biochem Pharmacol; 2001 Mar; 61(5):555-63. PubMed ID: 11239498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene.
    Nagata J; Kijima H; Hatanaka H; Asai S; Miyachi H; Abe Y; Yamazaki H; Nakamura M; Watanabe N; Mine T; Kondo T; Scanlon KJ; Ueyama Y
    Int J Oncol; 2002 Nov; 21(5):1021-6. PubMed ID: 12370750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line.
    Fujishima H; Nakano S; Masumoto N; Esaki T; Tatsumoto T; Kondo T; Niho Y
    Oncol Res; 1997; 9(4):167-72. PubMed ID: 9268987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel bicistronic retroviral vector expressing gamma-glutamylcysteine synthetase and the multidrug resistance protein 1 (MRP1) protects cells from MRP1-effluxed drugs and alkylating agents.
    Rappa G; Lorico A; Hildinger M; Fodstad Ø; Baum C
    Hum Gene Ther; 2001 Sep; 12(14):1785-96. PubMed ID: 11560771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation of MRP and gamma-glutamylcysteine synthetase overexpression with doxorubicin resistance due to increased apoptosis in SV40 large T-antigen-transformed human mesothelial cells.
    Ogretmen B; Bahadori H; McCauley M; Boylan A; Green M; Safa AR
    Cancer Chemother Pharmacol; 1998; 42(6):441-6. PubMed ID: 9788569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.